Antisense therapy directed to protein kinase C-alpha (affinitak, LY900003/ISIS 3521): Potential role in breast cancer
(Q35117571)
scientific article published on April 1, 2003
scientific article published on April 1, 2003
Language:
Current Data About
Antisense therapy directed to protein kinase C-alpha (affinitak, LY900003/ISIS 3521): Potential role in breast cancer
(P31) |
(Q13442814)
|
||||||||||||||||
(P304) |
30-33
|
||||||||||||||||
(P407) |
(Q1860)
|
||||||||||||||||
(P433) |
2 Suppl 3
|
||||||||||||||||
(P478) |
30
|
||||||||||||||||
(P577) |
Tuesday, April 1, 2003
|
||||||||||||||||
(P921) |
(Q162555)
|
||||||||||||||||
(P1433) |
(Q14330412)
|
||||||||||||||||
(P1476) |
"Antisense therapy directed to protein kinase C-alpha (Affinitak, LY900003/ISIS 3521): potential role in breast cancer" (language: en)
"Antisense therapy directed to protein kinase C-alpha (affinitak, LY900003/ISIS 3521): Potential role in breast cancer" (language: en)
|
||||||||||||||||
(P2093) |
Debasish Roychowdhury
Michael Lahn
|
||||||||||||||||
(P13046) |
(Q7318358)
|
other details
description | scientific article published on April 1, 2003 |
External Links
(P356) |
10.1053/SONC.2003.37273
|
(P698) |
12722024
|